PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 oct. 2022 09h00 HE
|
PharmaCyte Biotech, Inc.
LAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell...
PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer
26 juil. 2017 09h00 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors
10 juil. 2017 09h30 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event
06 juil. 2017 09h00 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
PharmaCyte Biotech to Present Pancreatic Cancer Therapy at 2017 BIO International Convention
13 juin 2017 09h20 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., June 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists
09 juin 2017 09h20 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
31 mai 2017 09h20 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Updates IND Submission Process in Interview with Facet Life Sciences
08 mai 2017 09h00 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors
02 mai 2017 09h00 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International
19 avr. 2017 09h20 HE
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...